Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Saturday, December 26, 2009, 10:24AM ET - U.S. Markets Closed. Dow Up 0.51% Nasdaq Up 0.71%
PolyMedix, Inc. (PYMX.OB)On Dec 24: 1.41  Up 0.05 (3.68%)  
MORE ON PYMX.OB
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Mon, Dec 21, 2009
POLYMEDIX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Dec 21)
Fri, Dec 18, 2009
PolyMedix Successfully Completes Main Portions of Phase 1B Clinical Study with PMX-30063 Novel Antibiotic Drug Candidate
Business Wire (Fri, Dec 18)
Wed, Dec 9, 2009
PolyMedix to Host Webcast on Heparin, Bleeding Complications, and PolyMedix's PMX-60056 Reversing Agent Tuesday, December 15, 2009 at 10:00am-EST
Business Wire (Wed, Dec 9)
Mon, Dec 7, 2009
Data on PolyMedix's Heptagonist Compounds to be Presented at Annual Meeting of the American Society of Hematology
Business Wire (Mon, Dec 7)
Fri, Nov 20, 2009
POLYMEDIX INC Financials
EDGAR Online Financials (Fri, Nov 20)
Tue, Nov 17, 2009
Merriman Curhan Ford Acted as Lead Placement Agent in PolyMedix's $20.7 Million Equity Financing
PR Newswire (Tue, Nov 17)
POLYMEDIX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 17)
PolyMedix completes $20M stock offering
at bizjournals.com (Tue, Nov 17)
PolyMedix Completes $20.7 Million Equity Financing
Business Wire (Tue, Nov 17)
Thu, Nov 12, 2009
POLYMEDIX INC Files SEC form 8-K, Other Events
EDGAR Online (Thu, Nov 12)
Skymark Research Initiates Independent Research Coverage On PolyMedix, Inc.
GlobeNewswire (Thu, Nov 12)
Wed, Nov 11, 2009
PolyMedix Inc. announces public offering
at bizjournals.com (Wed, Nov 11)
PolyMedix Announces Up To $21 Million Public Equity Offering
Business Wire (Wed, Nov 11)
Wed, Oct 28, 2009
POLYMEDIX INC Files SEC form 8-K, Other Events
EDGAR Online (Wed, Oct 28)
Tue, Oct 27, 2009
PolyMedix Completes Successful Phase 1B Clinical Study of Heparin Antagonist PMX-60056
Business Wire (Tue, Oct 27)
Tue, Sep 29, 2009
PolyMedix Initiates Dosing in Phase 1B Clinical Study of Novel Anticoagulant Antagonist Compound
Business Wire (Tue, Sep 29)
Mon, Sep 28, 2009
PolyMedix Receives U.S. Patent Protection for Licensed Computational Methods to Design Antimicrobial Polymers
Business Wire (Mon, Sep 28)
Mon, Jul 6, 2009
POLYMEDIX INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, Jul 6)
Tue, Jun 30, 2009
POLYMEDIX INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Tue, Jun 30)
Fri, May 22, 2009
POLYMEDIX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events
EDGAR Online (Fri, May 22)
Older Headlines - Download Recent Headlines
View headlines from:
Add PYMX.OB News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage